Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edap Tms Sa ADR (NQ: EDAP )

5.190 -0.140 (-2.63%)
Streaming Delayed Price Updated: 9:35 AM EDT, Jun 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edap Tms Sa ADR

< Previous 1 2 3 4 Next >
EDAP Announces Reimbursement Approval in Switzerland for the Use of High-Intensity Focused Ultrasound (HIFU) in the Treatment of Prostate Cancer
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Present at the Jefferies Healthcare Conference
From EDAP TMS S.A.
Via GlobeNewswire
Recap: Edap TMS Q1 Earnings
Via Benzinga
EDAP Announces First Quarter 2023 Financial Results
From EDAP TMS S.A.
Via GlobeNewswire
Edap TMS Earnings Preview
Via Benzinga
Edap TMS's Earnings: A Preview
Via Benzinga
EDAP to Announce First Quarter 2023 Financial Results on May 17, 2023
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Major Presence at Upcoming Annual Meeting of the American Urological Association (AUA)
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience
From EDAP TMS S.A.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
EDAP Announces Regulatory Clearance of ExactVu Micro-Ultrasound in Japan
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Reports Record Fourth Quarter and Full-Year 2022 Results and Announces Leadership Succession Plan to Develop Global Group Strategy
From EDAP TMS S.A.
Via GlobeNewswire
7 Biotech Stocks Sitting in the Sweet Spot
Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable. 
Via InvestorPlace
EDAP Presents Positive Results from Non-Inferiority Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy at EAU23
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Announce Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30th
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2022 Revenue
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis
From EDAP TMS S.A.
Via GlobeNewswire
IDEXX Laboratories Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
IDEXX Laboratories sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
EDAP Announces Record Q4 US Focal One Placements
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Appoints Medical Capital Equipment Finance Veteran Ken Mobeck as Chief Financial Officer of Company’s U.S. Subsidiary
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Approval to Initiate Randomized Clinical Trial Evaluating Focal One® as a Potential Treatment for Rectal Deep Infiltrating Endometriosis
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Present at the Piper Sandler 34th Annual Healthcare Conference
From EDAP TMS S.A.
Via GlobeNewswire
Intuit To $490? Here Are 5 Other Price Target Changes For Friday
Barclays cut Intuit Inc. (NASDAQ: INTU) price target from $502 to $490. . Barclays analyst Raimo Lenschow maintained an Overweight rating on the stock. Intuit shares fell 3% to close at $381.88 on... 
Via Benzinga
EDAP Reports Third Quarter 2022 Results
From EDAP TMS S.A.
Via GlobeNewswire
Earnings Outlook For Edap TMS
Edap TMS (NASDAQ:EDAP) is set to give its latest quarterly earnings report on Wednesday, 2022-11-16. Here's what investors need to know before the announcement. Analysts estimate that Edap TMS will... 
Via Benzinga
Earnings Scheduled For November 16, 2022
Companies Reporting Before The Bell • Golden Ocean Group (NASDAQ:GOGL) is estimated to report earnings for its third quarter. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Monopar Therapeutics (NASDAQ:MNPR) shares increased by 53.0% to $4.09 during Wednesday's pre-market session. The company's market cap stands at $52.0 million. 
Via Benzinga
EDAP TMS SA to Announce Third Quarter 2022 Financial Results on Wednesday, November 16th, 2022
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Focal One® HIFU Reimbursement Raised to Urology APC Level 6 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY23
From EDAP TMS S.A.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Upgrades 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.